Hoth Therapeutics Inc (HOTH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8556 -0.0031 (-0.36%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8554 -0.0002 (-0.02%) 19:59 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -8,188 | -8,106 | -11,372 | -14,314 | -7,198 |
Depreciation Amortization | N/A | N/A | N/A | N/A | 1 |
Accounts payable and accrued liabilities | 153 | -701 | 591 | 535 | -152 |
Other Working Capital | 405 | -487 | 595 | 530 | -132 |
Other Operating Activity | 652 | 847 | 889 | 1,158 | 1,347 |
Operating Cash Flow | $-6,978 | $-8,447 | $-9,298 | $-12,090 | $-6,133 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | N/A | 1,236 | -48 | -1,210 |
Net Acquisitions | N/A | N/A | N/A | N/A | -50 |
Purchase Of Investment | N/A | N/A | N/A | N/A | -410 |
Other Investing Activity | 0 | 0 | -74 | -117 | -168 |
Investing Cash Flow | $N/A | $N/A | $1,162 | $-165 | $-1,838 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 4,743 | 11,317 | 5,985 | 18,195 | 8,725 |
Other Financing Activity | 0 | 0 | 51 | 0 | 0 |
Financing Cash Flow | $4,743 | $11,317 | $6,036 | $18,195 | $8,725 |
Exchange Rate Effect | -18 | -7 | -10 | -31 | -15 |
Beginning Cash Position | 9,292 | 6,429 | 8,538 | 2,630 | 1,891 |
End Cash Position | 7,039 | 9,292 | 6,429 | 8,538 | 2,630 |
Net Cash Flow | $-2,253 | $2,864 | $-2,100 | $5,909 | $739 |
Free Cash Flow | |||||
Operating Cash Flow | -6,978 | -8,447 | -9,298 | -12,090 | -6,133 |
Free Cash Flow | -6,978 | -8,447 | -9,298 | -12,090 | -6,133 |